Delivery Order SPE2DB22D2005-SPE2DB26FJEP6
- Not listed
- The Defense Logistics Agency awarded a $5,858.87 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Xylocaine 2%-Epinephrine 1:200,000 in 10mL units. This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by August 21, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xylocaine 2%-Epinephrine 1:200,000 in 20mL vials, with a ceiling value of $1,477.46. The contract was awarded on July 21, 2025, under a firm fixed-price arrangement with an ultimate completion date of July 22, 2025. No set-aside designation was applied, indicating this was a competitively awarded contract. The point of performance is AmerisourceBergen Drug Corp's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,272.65 delivery order to AmerisourceBergen Drug Corp for 10 milliliters of Xylocaine 2%-Epinephrine 1:200,000, a local anesthetic with vasoconstrictor properties commonly used in medical and surgical procedures. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Xylocaine 2%-Epinephrine 1:200,000 20mL, a local anesthetic with vasoconstrictor agent commonly used in surgical and dental procedures. This firm fixed-price delivery order, valued at $1,022.62, was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The award was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xylocaine-MPF 1% Vial 5ML, a local anesthetic medication commonly used in medical and surgical applications. This firm fixed-price delivery order, valued at $2,413.46, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,946.55 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Lidocaine 1%-Epinephrine 1:100,000 in 30ML units, with a ceiling value of $1,803.85. This is a firm fixed-price delivery order with an ultimate completion date of March 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of XYLOCAINE 2%-EPI 1:200,000 20ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,218.78 and a performance period through March 20, 2024. This delivery order was issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,727.07, is for the delivery of XYLOCAINE 2%-EPI 1:200,000 20ML, a local anesthetic medication, with a completion date of January 5, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $1,776.00, is for the supply of 50 milliliter bottles of Xylocaine 1% with Epinephrine 1:100,000 medication. The delivery order has a performance period ending on March 29, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJEP6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Xylocaine 2%-Epinephrine 1:200,000 in 20ml vials, with a ceiling value of $1,219.54. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms that accommodate diverse medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/27/25 |